KATHLEEN LIMPENGCO
Nursing Service Providers|Registered Nurse|General Practice TEMECULA, CA NPI 1992427751
Browse related groups: Nursing Service Providers|Registered Nurse|General Practice CA Acerta Pharma LLC All categories
General Payments — all program years on this page
$251.65
- Category: General Payments
- Program years: PY2022–2024
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $168.70 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $168.70 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $54.27 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.82 | 1 |
| Teva Pharmaceuticals USA, Inc. | $28.62 | 1 |
| Astellas Pharma US Inc | $22.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.26 | 1 |
| Lilly USA, LLC | $16.32 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087155758 | Novartis Pharmaceuticals Corporation | $18.26 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104748367 | AstraZeneca Pharmaceuticals LP | $26.18 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105868601 | AstraZeneca Pharmaceuticals LP | $28.09 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135764947 | Lilly USA, LLC | $16.32 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137781886 | Takeda Pharmaceuticals U.S.A., Inc. | $28.82 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139513567 | Astellas Pharma US Inc | $22.41 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151520085 | Teva Pharmaceuticals USA, Inc. | $28.62 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.